(Q34151703)

31 July 2017

In vivo effects of IgA and IgG2a anti-CD3 isotype switch variants (English)

1 reference

31 July 2017

Parlevliet KJ

1

1 reference

31 July 2017

ten Berge IJ

2

1 reference

31 July 2017

Yong SL

3

1 reference

31 July 2017

Surachno J

4

1 reference

31 July 2017

Wilmink JM

5

1 reference

31 July 2017

Schellekens PT

6

1 reference

31 July 2017

language of work or name

English

0 references

publication date

1 June 1994

1 reference

Journal of Clinical Investigation

31 July 2017

1 reference

31 July 2017

93

1 reference

31 July 2017

6

1 reference

31 July 2017

2519-2525

1 reference

Human in vivo antigenic modulation induced by the anti-T cell OKT3 monoclonal antibody.

31 July 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=294472

Bacterial-lipopolysaccharide-induced release of lactoferrin from human polymorphonuclear leukocytes: role of monocyte-derived tumor necrosis factor alpha

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=294472

Prophylactic use of OKT3 monoclonal antibody in cadaver kidney recipients. Utilization of OKT3 as the sole immunosuppressive agent

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=294472

Induction of T cell proliferation with anti-CD3 switch-variant monoclonal antibodies: effects of heavy chain isotype in monocyte-dependent systems

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=294472

Effect of tumor necrosis factor and granulocyte/macrophage colony-stimulating factor on neutrophil degranulation

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=294472

Release of tumor necrosis factor, interleukin-2, and gamma-interferon in serum after injection of OKT3 monoclonal antibody in kidney transplant recipients

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=294472

Muromonab CD3. A review of its pharmacology and therapeutic potential

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=294472

T cells from patients successfully treated with OKT3 do not react with the T-cell receptor antibody

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=294472

Activation of coagulation after administration of tumor necrosis factor to normal subjects

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=294472

Anti-CD3 murine monoclonal isotype switch variants tested for toxicity and immunologic monitoring in four chimpanzees

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=294472

Kinetics of interleukin 6 during OKT3 treatment in renal allograft recipients

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=294472

In vivo cell activation following OKT3 administration. Systemic cytokine release and modulation by corticosteroids

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=294472

Anti-TNF abrogates the cytokine-related anti-CD3 induced syndrome

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=294472

Fibrinolytic response to tumor necrosis factor in healthy subjects

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=294472

Evidence that antihuman tumor necrosis factor monoclonal antibody prevents OKT3-induced acute syndrome

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=294472

Monoclonal antibodies in renal transplantation: a review

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=294472

Induction of thromboses within renal grafts by high-dose prophylactic OKT3

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=294472

OKT3 F(ab')2 fragments--retention of the immunosuppressive properties of whole antibody with marked reduction in T cell activation and lymphokine release

5 July 2018

1 reference

12 December 2020

Plasma elastase alpha 1-antitrypsin and lactoferrin in sepsis: evidence for neutrophils as mediators in fatal sepsis

1 reference

12 December 2020

Thromboembolic complications and dose of monoclonal OKT3 antibody

1 reference

12 December 2020

Plasminogen activation in vivo upon intravenous infusion of DDAVP. Quantitative assessment of plasmin-alpha 2-antiplasmin complex with a novel monoclonal antibody based radioimmunoassay

1 reference

12 December 2020

Inflammatory mediator release from human monocytes via immobilized Fc receptors. Its potential role in adverse reactions to systemic monoclonal antibody therapy

1 reference

12 December 2020

Activation of coagulation and fibrinolysis following OKT3 administration to renal transplant recipients: association with distinct mediators

1 reference

12 December 2020

Complement activation during OKT3 treatment: a possible explanation for respiratory side effects

1 reference

12 December 2020

Application of a monoclonal antibody against a neoepitope on activated C4 in an ELISA for the quantification of complement activation via the classical pathway

1 reference

12 December 2020

Fc receptors for mouse IgG1 on human monocytes: polymorphism and role in antibody-induced T cell proliferation

1 reference

12 December 2020

Mechanisms by which accessory cells contribute in growth of resting T lymphocytes initiated by OKT3 antibody

1 reference

12 December 2020

Restriction of the human in vivo immune response against the mouse monoclonal antibody OKT3

1 reference

12 December 2020

Two monoclonal anti-CD3 antibodies can induce different events in human T lymphocyte activation

1 reference

12 December 2020

Murine monoclonal isotype switch variants. Detection with rat monoclonal antibodies in ELISA and isolation by sequential sublining

1 reference

12 December 2020

Complications and monitoring of OKT3 therapy

1 reference

12 December 2020

A modified competitive inhibition radioimmunoassay for the detection of C3a. Use of 125I-C3 instead of 125I-C3a

1 reference

12 December 2020

Fc-receptor cross-linking induces rapid secretion of tumor necrosis factor (cachectin) by human peripheral blood monocytes

1 reference

12 December 2020

Effects of in vivo administration of anti-CD3 monoclonal antibody on T cell function in mice. II. In vivo activation of T cells

1 reference

12 December 2020

Discordant expression of CD3 and T-cell receptor antigens on lymphocytes from patients treated with OKT3

1 reference

12 December 2020

Systemic reaction to the anti-T-cell monoclonal antibody OKT3 in relation to serum levels of tumor necrosis factor and interferon-gamma [corrected]

1 reference

12 December 2020

OKT3-induced cytokine release attenuation by high-dose methylprednisolone

1 reference

12 December 2020

1 reference

12 December 2020

Anti-CD3 F(ab')2 fragments are immunosuppressive in vivo without evoking either the strong humoral response or morbidity associated with whole mAb

1 reference

12 December 2020

Reduction of morbidity and cytokine release in anti-CD3 MoAb-treated mice by corticosteroids

1 reference

12 December 2020

Cytokine release syndrome induced by the 145-2C11 anti-CD3 monoclonal antibody in mice: prevention by high doses of methylprednisolone

1 reference

12 December 2020

Corticosteroid inhibition of the OKT3-induced cytokine-related syndrome--dosage and kinetics prerequisites

1 reference

12 December 2020

OKT3 first-dose reaction: association with T cell subsets and cytokine release

1 reference

12 December 2020

The role of antibody isotype in IFN-gamma and IL-2 production during anti-CD3-induced T cell proliferation

1 reference

12 December 2020

Sensitive ELISA for interleukin-6. Detection of IL-6 in biological fluids: synovial fluids and sera

1 reference

12 December 2020

Effects on leukocytes after injection of tumor necrosis factor into healthy humans

1 reference

12 December 2020

Identifiers

DOI

10.1172/JCI117262

1 reference

31 July 2017

1 reference

31 July 2017

1 reference